SFRS2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.098960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.272200E-01
Normal-vs-Stage2
6.567700E-02
Normal-vs-Stage3
4.037900E-02
Normal-vs-Stage4
9.419400E-01
Stage1-vs-Stage2
6.241600E-01
Stage1-vs-Stage3
1.478440E-01
Stage1-vs-Stage4
2.530600E-01
Stage2-vs-Stage3
1.653600E-01
Stage2-vs-Stage4
2.555700E-02
Stage3-vs-Stage4
7.522000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.016640E-01
Normal-vs-AfricanAmerican
7.336400E-01
Normal-vs-Asian
6.539800E-02
Caucasian-vs-AfricanAmerican
7.719600E-02
Caucasian-vs-Asian
4.618200E-01
AfricanAmerican-vs-Asian
5.105900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.756400E-02
Normal-vs-Female
2.208800E-01
Male-vs-Female
2.094800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.233200E-01
Normal-vs-Age(41-60Yrs)
1.309600E-01
Normal-vs-Age(61-80Yrs)
1.236010E-01
Normal-vs-Age(81-100Yrs)
4.085700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.198000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.511600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.368000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.751800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.750800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.929600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.154300E-02
Normal-vs-Daily Drinker
1.129600E-01
Normal-vs-Weekly Drinker
2.050100E-02
Normal-vs-Occasional Drinker
6.323800E-01
Normal-vs-Social Drinker
3.193900E-02
Non Drinker-vs-Daily Drinker
7.585000E-01
Non Drinker-vs-Weekly Drinker
1.654750E-01
Non Drinker-vs-Occasional Drinker
5.743800E-02
Non Drinker-vs-Social Drinker
7.557000E-01
Daily Drinker-vs-Weekly Drinker
1.595600E-01
Daily Drinker-vs-Occasional Drinker
1.029160E-01
Daily Drinker-vs-Social Drinker
9.948000E-01
Weekly Drinker-vs-Occasional Drinker
1.321770E-02
Weekly Drinker-vs-Social Drinker
1.162610E-01
Occasional Drinker-vs-Social Drinker
9.423700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.552290E-02
Normal-vs-Grade 2
4.391200E-04
Normal-vs-Grade 3
4.783600E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.645200E-01
Grade 1-vs-Grade 3
6.792600E-01
Grade 1-vs-Grade 4
1.552290E-02
Grade 2-vs-Grade 3
9.980400E-01
Grade 2-vs-Grade 4
4.391200E-04
Grade 3-vs-Grade 4
4.783600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.622300E-02
Normal-vs-NonDiabetic
1.015780E-01
Diabetic-vs-NonDiabetic
2.637000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.059800E-02
Normal-vs-NoPancreatitis
1.067020E-01
Pancreatitis-vs-NoPancreatitis
3.542200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.313800E-01
Normal-vs-N1
8.317700E-02
N0-vs-N1
4.345200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.089200E-01
Normal-vs-TP53-NonMutant
4.307600E-01
TP53-Mutant-vs-TP53-NonMutant
7.629600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
